심혈관 건강보조제 시장 규모, 점유율, 성장 및 세계 산업 분석 : 종류별, 용도별, 지역별 인사이트와 예측(2026-2034년)

Growth Factors of cardiovascular health supplements Market

The global cardiovascular health supplements market is witnessing steady growth due to rising awareness about heart health and the increasing prevalence of cardiovascular diseases worldwide. According to Fortune Business Insights, the market was valued at USD 12.31 billion in 2025 and is projected to grow to USD 13.0 billion in 2026. Over the forecast period, the market is expected to reach USD 21.51 billion by 2034, registering a CAGR of 6.50% from 2026 to 2034.

North America dominated the cardiovascular health supplements market with a 40.98% share in 2025, supported by high health awareness, strong preventive healthcare adoption, and a growing aging population.

Market Overview

Cardiovascular health supplements support heart function by helping manage cholesterol levels, blood pressure, and overall vascular health. These supplements include omega-3 fatty acids, fish oil, red yeast rice, Coenzyme Q10 (CoQ10), fiber, sterols, flaxseed oil, and various herbal extracts. Growing lifestyle-related health issues such as obesity, poor diet, and sedentary behavior have significantly increased the risk of heart disease, driving demand for preventive nutritional solutions.

The market is also benefiting from the rising focus of elderly populations on maintaining heart health through high-quality conventional and natural supplements, reducing the risk of complications related to cardiovascular diseases.

Impact of COVID-19

The COVID-19 pandemic had a positive impact on the cardiovascular health supplements market. Increased focus on immunity and heart health led to higher consumption of supplements. During the pandemic, key manufacturers experienced revenue growth due to rising adoption of heart health supplements. Post-pandemic, the market continues to grow steadily as awareness of preventive healthcare remains strong. Increased advertising and promotional campaigns by supplement manufacturers further support market expansion.

Market Trends

Increasing Shift Toward Natural Ingredients

One of the most prominent trends is the growing preference for natural cardiovascular health supplements. Consumers are increasingly choosing products with clean-label, plant-based, and herbal ingredients due to concerns about the side effects of synthetic nutrients. Natural supplements are perceived as safer for long-term consumption and beneficial for improving blood circulation, energy levels, and heart function. This shift is encouraging manufacturers to launch innovative products with natural formulations.

Market Growth Drivers

Rising Prevalence of Cardiovascular Diseases

The increasing incidence of cardiovascular conditions such as arrhythmia, coronary artery disease, hypertension, and stroke is a major driver of market growth. Sedentary lifestyles and unhealthy dietary habits are contributing to a rising burden of heart disease across both developed and developing regions. As a preventive approach, a growing number of individuals are incorporating cardiovascular supplements into their daily routines.

Increasing Product Launches

The growing consumption of dietary supplements has encouraged both established and new players to introduce innovative cardiovascular health products. Manufacturers are developing supplements in various dosage forms such as capsules, tablets, and gummies to attract a broader consumer base. This rising product innovation and availability are accelerating market growth.

Restraining Factors

Availability of Counterfeit Products

Despite strong growth, the market faces challenges from the increasing availability of counterfeit and misbranded supplements. The inability of consumers to distinguish between approved products and unauthorized supplements limits adoption. Regulatory warnings issued against misbranded heart health supplements highlight the need for stricter quality control and consumer education.

Segmentation Analysis

By Type

Based on type, the market is segmented into natural supplements and synthetic supplements.

The natural supplements segment dominated with a 60.63% share in 2026, driven by consumer preference for plant-based and herbal ingredients. The synthetic supplements segment also holds a notable share due to their cost-effectiveness and clinical research support.

By Ingredients

The vitamins & minerals segment dominated with a 42.23% market share in 2026, supported by their role in maintaining blood pressure, reducing inflammation, and improving vascular function. Herbal extracts and other ingredients such as omega-3 fatty acids and CoQ10 are also gaining traction.

By Dosage Form

The capsules segment led the market with a 51.90% share in 2026, owing to ease of consumption, quick absorption, and availability in multiple dosages. Tablets and gummies are also witnessing increasing adoption.

By Distribution Channel

Drug stores and retail pharmacies dominate distribution due to easy accessibility and consumer trust. Online pharmacies are expected to grow steadily due to convenience and expanding e-commerce penetration.

Regional Insights

North America generated USD 5.05 billion in revenue in 2025, maintaining its leading position due to high awareness and strong manufacturer presence. Europe holds a significant share due to rising demand for plant-based supplements. Asia Pacific is witnessing rapid growth driven by increasing cardiovascular disease prevalence and growing acceptance of preventive healthcare.

Competitive Landscape

The market is fragmented, with key players including Amway, Thorne, Herbalife, Swisse Wellness, Gaia Herbs, and NOW FOODS. Companies are focusing on certifications, collaborations, and innovative product launches to strengthen their market position.

Conclusion

The global cardiovascular health supplements market, valued at USD 12.31 billion in 2025, is projected to reach USD 13.0 billion in 2026 and USD 21.51 billion by 2034. Rising cardiovascular disease prevalence, increasing preference for natural supplements, and continuous product innovation are expected to support market growth during the forecast period.

Segmentation

By Type

• Natural Supplements
• Synthetic Supplements

By Ingredients

• Vitamins and Minerals
• Herbal Extracts
• Others

By Dosage Form

• Tablets
• Capsules
• Others

By Distribution Channel

• Hospital Pharmacies
• Drug Stores & Retail Pharmacies
• Online Pharmacies
• Others

By Region

• North America (By Type, Ingredients, Dosage Form, Distribution Channel, and Country)
  • U.S.
  • Canada
• Europe (By Type, By Ingredients, Dosage Form, Distribution Channel, and Country/Sub-Region)
  • U.K
  • Germany
  • France
  • Spain
  • Italy
  • Scandinavia
  • Rest of Europe
• Asia Pacific (By Type, Ingredients, Dosage Form, Distribution Channel, and Country/Sub-Region)
  • Japan
  • China
  • India
  • Australia
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America (By Type, Ingredients, Dosage Form, Distribution Channel, and Country/Sub-Region)
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa (By Type, Ingredients, Dosage Form, Distribution Channel, and Country/Sub-Region)
  • GCC
  • South Africa
  • Rest of the Middle East & Africa

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. Overview: Advancements in Cardiovascular Health Supplements
• 4.2. New Product Launches, By Key Players
• 4.3. Key Industry Developments, By Key Players
• 4.4. Prevalence of Key Cardiovascular Diseases, By Key Countries
• 4.5. Impact of COVID-19 on the Market

5. Global Cardiovascular Health Supplements Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Market Analysis, Insights and Forecast - By Type
  • 5.1.1. Natural Supplements
  • 5.1.2. Synthetic Supplements
• 5.2. Market Analysis, Insights and Forecast - By Ingredients
  • 5.2.1. Vitamins and Minerals
  • 5.2.2. Herbal Extracts
  • 5.2.3. Others
• 5.3. Market Analysis, Insights and Forecast - By Dosage Form
  • 5.3.1. Tablets
  • 5.3.2. Capsules
  • 5.3.3. Others
• 5.4. Market Analysis, Insights and Forecast - By Distribution Channel
  • 5.4.1. Hospital Pharmacies
  • 5.4.2. Drug Stores & Retail Pharmacies
  • 5.4.3. Online Pharmacies
  • 5.4.4. Others
• 5.5. Market Analysis, Insights and Forecast - By Region
  • 5.5.1. North America
  • 5.5.2. Europe
  • 5.5.3. Asia Pacific
  • 5.5.4. Latin America
  • 5.5.5. Middle East & Africa

6. North America Cardiovascular Health Supplements Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Market Analysis, Insights and Forecast - By Type
  • 6.1.1. Natural Supplements
  • 6.1.2. Synthetic Supplements
• 6.2. Market Analysis, Insights and Forecast - By Ingredients
  • 6.2.1. Vitamins and Minerals
  • 6.2.2. Herbal Extracts
  • 6.2.3. Others
• 6.3. Market Analysis, Insights and Forecast - By Dosage Form
  • 6.3.1. Tablets
  • 6.3.2. Capsules
  • 6.3.3. Others
• 6.4. Market Analysis, Insights and Forecast - By Distribution Channel
  • 6.4.1. Hospital Pharmacies
  • 6.4.2. Drug Stores & Retail Pharmacies
  • 6.4.3. Online Pharmacies
  • 6.4.4. Others
• 6.5. Market Analysis, Insights and Forecast - By Country
  • 6.5.1. U.S.
  • 6.5.2. Canada

7. Europe Cardiovascular Health Supplements Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Market Analysis, Insights and Forecast - By Type
  • 7.1.1. Natural Supplements
  • 7.1.2. Synthetic Supplements
• 7.2. Market Analysis, Insights and Forecast - By Ingredients
  • 7.2.1. Vitamins and Minerals
  • 7.2.2. Herbal Extracts
  • 7.2.3. Others
• 7.3. Market Analysis, Insights and Forecast - By Dosage Form
  • 7.3.1. Tablets
  • 7.3.2. Capsules
  • 7.3.3. Others
• 7.4. Market Analysis, Insights and Forecast - By Distribution Channel
  • 7.4.1. Hospital Pharmacies
  • 7.4.2. Drug Stores & Retail Pharmacies
  • 7.4.3. Online Pharmacies
  • 7.4.4. Others
• 7.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
  • 7.5.1. Germany
  • 7.5.2. U.K
  • 7.5.3. France
  • 7.5.4. Italy
  • 7.5.5. Spain
  • 7.5.6. Scandinavia
  • 7.5.7. Rest of Europe

8. Asia Pacific Cardiovascular Health Supplements Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Market Analysis, Insights and Forecast - By Type
  • 8.1.1. Natural Supplements
  • 8.1.2. Synthetic Supplements
• 8.2. Market Analysis, Insights and Forecast - By Ingredients
  • 8.2.1. Vitamins and Minerals
  • 8.2.2. Herbal Extracts
  • 8.2.3. Others
• 8.3. Market Analysis, Insights and Forecast - By Dosage Form
  • 8.3.1. Tablets
  • 8.3.2. Capsules
  • 8.3.3. Others
• 8.4. Market Analysis, Insights and Forecast - By Distribution Channel
  • 8.4.1. Hospital Pharmacies
  • 8.4.2. Drug Stores & Retail Pharmacies
  • 8.4.3. Online Pharmacies
  • 8.4.4. Others
• 8.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
  • 8.5.1. China
  • 8.5.2. India
  • 8.5.3. Japan
  • 8.5.4. Australia
  • 8.5.5. Southeast Asia
  • 8.5.6. Rest of Asia Pacific

9. Latin America Cardiovascular Health Supplements Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Market Analysis, Insights and Forecast - By Type
  • 9.1.1. Natural Supplements
  • 9.1.2. Synthetic Supplements
• 9.2. Market Analysis, Insights and Forecast - By Ingredients
  • 9.2.1. Vitamins and Minerals
  • 9.2.2. Herbal Extracts
  • 9.2.3. Others
• 9.3. Market Analysis, Insights and Forecast - By Dosage Form
  • 9.3.1. Tablets
  • 9.3.2. Capsules
  • 9.3.3. Others
• 9.4. Market Analysis, Insights and Forecast - By Distribution Channel
  • 9.4.1. Hospital Pharmacies
  • 9.4.2. Drug Stores & Retail Pharmacies
  • 9.4.3. Online Pharmacies
  • 9.4.4. Others
• 9.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
  • 9.5.1. Brazil
  • 9.5.2. Mexico
  • 9.5.3. Rest of Latin America

10. Middle East & Africa Cardiovascular Health Supplements Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Market Analysis, Insights and Forecast - By Type
  • 10.1.1. Natural Supplements
  • 10.1.2. Synthetic Supplements
• 10.2. Market Analysis, Insights and Forecast - By Ingredients
  • 10.2.1. Vitamins and Minerals
  • 10.2.2. Herbal Extracts
  • 10.2.3. Others
• 10.3. Market Analysis, Insights and Forecast - By Dosage Form
  • 10.3.1. Tablets
  • 10.3.2. Capsules
  • 10.3.3. Others
• 10.4. Market Analysis, Insights and Forecast - By Distribution Channel
  • 10.4.1. Hospital Pharmacies
  • 10.4.2. Drug Stores & Retail Pharmacies
  • 10.4.3. Online Pharmacies
  • 10.4.4. Others
• 10.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
  • 10.5.1. GCC
  • 10.5.2. South Africa
  • 10.5.3. Rest of Middle East & Africa

11. Competitive Analysis

• 11.1. Global Market Share Analysis (2025)
• 11.2. Company Profiles
  • 11.2.1. Amway
    • 11.2.1.1. Overview
    • 11.2.1.2. Products & Services
    • 11.2.1.3. SWOT Analysis
    • 11.2.1.4. Recent Developments
    • 11.2.1.5. Strategies
    • 11.2.1.6. Financials (Based on Availability)
  • 11.2.2. Thorne
    • 11.2.2.1. Overview
    • 11.2.2.2. Products & Services
    • 11.2.2.3. SWOT Analysis
    • 11.2.2.4. Recent Developments
    • 11.2.2.5. Strategies
    • 11.2.2.6. Financials (Based on Availability)
  • 11.2.3. Swisse Wellness Pty Ltd
    • 11.2.3.1. Overview
    • 11.2.3.2. Products & Services
    • 11.2.3.3. SWOT Analysis
    • 11.2.3.4. Recent Developments
    • 11.2.3.5. Strategies
    • 11.2.3.6. Financials (Based on Availability)
  • 11.2.4. Herbalife International of America, Inc.
    • 11.2.4.1. Overview
    • 11.2.4.2. Products & Services
    • 11.2.4.3. SWOT Analysis
    • 11.2.4.4. Recent Developments
    • 11.2.4.5. Strategies
    • 11.2.4.6. Financials (Based on Availability)
  • 11.2.5. BL Bio Lab, LLC.
    • 11.2.5.1. Overview
    • 11.2.5.2. Products & Services
    • 11.2.5.3. SWOT Analysis
    • 11.2.5.4. Recent Developments
    • 11.2.5.5. Strategies
    • 11.2.5.6. Financials (Based on Availability)
  • 11.2.6. Church & Dwight Co., Inc.
    • 11.2.6.1. Overview
    • 11.2.6.2. Products & Services
    • 11.2.6.3. SWOT Analysis
    • 11.2.6.4. Recent Developments
    • 11.2.6.5. Strategies
    • 11.2.6.6. Financials (Based on Availability)
  • 11.2.7. Vyta Health Limited.
    • 11.2.7.1. Overview
    • 11.2.7.2. Products & Services
    • 11.2.7.3. SWOT Analysis
    • 11.2.7.4. Recent Developments
    • 11.2.7.5. Strategies
    • 11.2.7.6. Financials (Based on Availability)
  • 11.2.8. Gaia Herbs
    • 11.2.8.1. Overview
    • 11.2.8.2. Products & Services
    • 11.2.8.3. SWOT Analysis
    • 11.2.8.4. Recent Developments
    • 11.2.8.5. Strategies
    • 11.2.8.6. Financials (Based on Availability)
  • 11.2.9. Herb Pharm
    • 11.2.9.1. Overview
    • 11.2.9.2. Products & Services
    • 11.2.9.3. SWOT Analysis
    • 11.2.9.4. Recent Developments
    • 11.2.9.5. Strategies
    • 11.2.9.6. Financials (Based on Availability)